A Critical Role for TNF Receptor-Associated Factor 1 and Bim Down-Regulation in CD8 Memory T Cell Survival
Total Page:16
File Type:pdf, Size:1020Kb

Load more
Recommended publications
-
Mechanism of Action Through an IFN Type I-Independent Responses To
Downloaded from http://www.jimmunol.org/ by guest on September 25, 2021 is online at: average * The Journal of Immunology , 12 of which you can access for free at: 2012; 188:3088-3098; Prepublished online 20 from submission to initial decision 4 weeks from acceptance to publication February 2012; doi: 10.4049/jimmunol.1101764 http://www.jimmunol.org/content/188/7/3088 MF59 and Pam3CSK4 Boost Adaptive Responses to Influenza Subunit Vaccine through an IFN Type I-Independent Mechanism of Action Elena Caproni, Elaine Tritto, Mario Cortese, Alessandro Muzzi, Flaviana Mosca, Elisabetta Monaci, Barbara Baudner, Anja Seubert and Ennio De Gregorio J Immunol cites 33 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription http://www.jimmunol.org/content/suppl/2012/02/21/jimmunol.110176 4.DC1 This article http://www.jimmunol.org/content/188/7/3088.full#ref-list-1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material References Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2012 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 -
Expression of the Tumor Necrosis Factor Receptor-Associated Factors
Expression of the Tumor Necrosis Factor Receptor- Associated Factors (TRAFs) 1 and 2 is a Characteristic Feature of Hodgkin and Reed-Sternberg Cells Keith F. Izban, M.D., Melek Ergin, M.D, Robert L. Martinez, B.A., HT(ASCP), Serhan Alkan, M.D. Department of Pathology, Loyola University Medical Center, Maywood, Illinois the HD cell lines. Although KMH2 showed weak Tumor necrosis factor receptor–associated factors expression, the remaining HD cell lines also lacked (TRAFs) are a recently established group of proteins TRAF5 protein. These data demonstrate that consti- involved in the intracellular signal transduction of tutive expression of TRAF1 and TRAF2 is a charac- several members of the tumor necrosis factor recep- teristic feature of HRS cells from both patient and tor (TNFR) superfamily. Recently, specific members cell line specimens. Furthermore, with the excep- of the TRAF family have been implicated in promot- tion of TRAF1 expression, HRS cells from the three ing cell survival as well as activation of the tran- HD cell lines showed similar TRAF protein expres- scription factor NF- B. We investigated the consti- sion patterns. Overall, these findings demonstrate tutive expression of TRAF1 and TRAF2 in Hodgkin the expression of several TRAF proteins in HD. Sig- and Reed–Sternberg (HRS) cells from archived nificantly, the altered regulation of selective TRAF paraffin-embedded tissues obtained from 21 pa- proteins may reflect HRS cell response to stimula- tients diagnosed with classical Hodgkin’s disease tion from the microenvironment and potentially (HD). In a selective portion of cases, examination of contribute both to apoptosis resistance and cell HRS cells for Epstein-Barr virus (EBV)–encoded maintenance of HRS cells. -
Systematic Examination of Antigen-Specific Recall T Cell
Systematic Examination of Antigen-Specific Recall T Cell Responses to SARS-CoV-2 versus Influenza Virus Reveals a Distinct Inflammatory Profile This information is current as of November 24, 2020. Jaclyn C. Law, Wan Hon Koh, Patrick Budylowski, Jonah Lin, FengYun Yue, Kento T. Abe, Bhavisha Rathod, Melanie Girard, Zhijie Li, James M. Rini, Samira Mubareka, Allison McGeer, Adrienne K. Chan, Anne-Claude Gingras, Tania H. Watts and Mario A. Ostrowski Downloaded from J Immunol published online 18 November 2020 http://www.jimmunol.org/content/early/2020/11/17/jimmun ol.2001067 http://www.jimmunol.org/ Supplementary http://www.jimmunol.org/content/suppl/2020/11/17/jimmunol.200106 Material 7.DCSupplemental Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on November 24, 2020 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Author Choice Freely available online through The Journal of Immunology Author Choice option Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2020 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published November 18, 2020, doi:10.4049/jimmunol.2001067 The Journal of Immunology Systematic Examination of Antigen-Specific Recall T Cell Responses to SARS-CoV-2 versus Influenza Virus Reveals a Distinct Inflammatory Profile Jaclyn C. -
Crystallographic Analysis of CD40 Recognition and Signaling by Human TRAF2
Proc. Natl. Acad. Sci. USA Vol. 96, pp. 8408–8413, July 1999 Biochemistry Crystallographic analysis of CD40 recognition and signaling by human TRAF2 SARAH M. MCWHIRTER*, STEVEN S. PULLEN†,JAMES M. HOLTON*, JAMES J. CRUTE†,MARILYN R. KEHRY†, AND TOM ALBER*‡ *Department of Molecular and Cell Biology, University of California, Berkeley, CA 94720-3206, and †Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877-0368 Communicated by Peter S. Kim, Massachusetts Institute of Technology, Cambridge, MA, May 26, 1999 (received for review April 25, 1999) ABSTRACT Tumor necrosis factor receptor superfamily proteins (8, 9). The biological selectivity of signaling also relies members convey signals that promote diverse cellular re- on the oligomerization specificity and receptor affinity of the sponses. Receptor trimerization by extracellular ligands ini- TRAFs. tiates signaling by recruiting members of the tumor necrosis The TNF receptor superfamily member, CD40, mediates factor receptor-associated factor (TRAF) family of adapter diverse responses. In antigen-presenting cells that constitu- proteins to the receptor cytoplasmic domains. We report the tively express CD40, it plays a critical role in T cell-dependent 2.4-Å crystal structure of a 22-kDa, receptor-binding fragment immune responses (10). TRAF1, TRAF2, TRAF3, and of TRAF2 complexed with a functionally defined peptide from TRAF6 binding sites in the 62-aa, CD40 cytoplasmic domain the cytoplasmic domain of the CD40 receptor. TRAF2 forms have been mapped (7, 11). TRAF1, TRAF2, and TRAF3 bind a mushroom-shaped trimer consisting of a coiled coil and a to the same sequence, 250PVQET, and TRAF6 binds to the unique -sandwich domain. Both domains mediate trimer- membrane-proximal sequence, 231QEPQEINF. -
TRAF6, a Molecular Bridge Spanning Adaptive Immunity, Innate Immunity and Osteoimmunology Hao Wu1* and Joseph R
Review articles TRAF6, a molecular bridge spanning adaptive immunity, innate immunity and osteoimmunology Hao Wu1* and Joseph R. Arron2 Summary receptor/Toll-like receptor (IL-1R/TLR) superfamily. Gene Tumor necrosis factor (TNF) receptor associated factor targeting experiments have identified several indispen- 6 (TRAF6) is a crucial signaling molecule regulating a sable physiological functions of TRAF6, and structural diverse array of physiological processes, including and biochemical studies have revealed the potential adaptive immunity, innate immunity, bone metabolism mechanisms of its action. By virtue of its many signaling and the development of several tissues including lymph roles, TRAF6 represents an important target in the regu- nodes, mammary glands, skin and the central nervous lation of many disease processes, including immunity, system. It is a member of a group of six closely related inflammation and osteoporosis. BioEssays 25:1096– TRAF proteins, which serve as adapter molecules, coupl- 1105, 2003. ß 2003 Wiley Periodicals, Inc. ing the TNF receptor (TNFR) superfamily to intracellular signaling events. Among the TRAF proteins, TRAF6 is unique in that, in addition to mediating TNFR family Introduction signaling, it is also essential for signaling downstream of The tumor necrosis factor (TNF) receptor associated factors an unrelated family of receptors, the interleukin-1 (IL-1) (TRAFs) were first identified as two intracellular proteins, TRAF1 and TRAF2, associated with TNF-R2,(1) a member of 1Department of Biochemistry, Weill Medical College of Cornell the TNF receptor (TNFR) superfamily. There are currently six University, New York. mammalian TRAFs (TRAF1-6), which have emerged as 2Tri-Institutional MD-PhD Program, Weill Medical College of Cornell important proximal signal transducers for the TNFR super- University, New York. -
Receptor Activator of NF-UB Recruits Multiple TRAF Family Adaptors and Activates C-Jun N-Terminal Kinase
FEBS 21470 FEBS Letters 443 (1999) 297^302 Receptor activator of NF-UB recruits multiple TRAF family adaptors and activates c-Jun N-terminal kinase Hong-Hee Kima, Da Eun Leea, Jin Na Shina, Yong Soo Leea, Yoo Mi Jeona, Chae-Heon Chunga, Jian Nib, Byoung Se Kwonc, Zang Hee Leea;* aDepartment of Microbiology and Immunology, Chosun University Dental School, 375 Seosuk-Dong, Dong-Ku, Kwangju 501-759, South Korea bHuman Genome Sciences, Inc., Rockville, MD 20850, USA cDepartment of Life Sciences, Ulsan University, Ulsan, South Korea Received 7 December 1998 trabecular bone and lower in spleen and bone marrow [3], Abstract Receptor activator of NF-UB (RANK) is a recently cloned member of the tumor necrosis factor receptor (TNFR) which suggests physiological functions of RANK in the regu- superfamily, and its function has been implicated in osteoclast lation of bone and immune systems. Consistent with this differentiation and dendritic cell survival. Many of the TNFR suggestion, treatment with RANKL/TRANCE was shown family receptors recruit various members of the TNF receptor- to enhance the function and survival of T cells and dendritic associated factor (TRAF) family for transduction of their signals cells [1,5]. In addition, RANKL/ODF has been demonstrated to NF-UB and c-Jun N-terminal kinase. In this study, the to cause the di¡erentiation of hematopoietic precursor cells involvement of TRAF family members and the activation of the into osteoclasts and to stimulate the bone resorbing activity JNK pathway in signal transduction by RANK were investi- of mature osteoclasts [4]. gated. TRAF1, 2, 3, 5, and 6 were found to bind RANK in vitro. -
Dr. Tania Watts
Interviews Interview with an Immunologist: Dr. Tania Watts Dario M. Ferri and Luke S. Dingwell r. Tania Watts received her After the initial shock dissipated, I started to think Well,“ Ph.D. in Biochemistry from we’re experts in viral immunology, we should do something” - the University of Alberta. She fortunately, I have colleagues in Dr. Mario Ostrowski and Dr. Dthen went on to do a post-doctoral Allison McGeer, both infectious diseases clinician scientists, fellowship at Stanford University so I reached out to them about the possibility of setting up studying T lymphocyte activation, which a project focused on studying human T cell responses to is where she first began to develop her SARS-CoV-2. Once we finalized our idea for the project, passion for immunology. During her there was a bit of a scramble to get all of the necessary post-doctoral work, Dr. Watts helped biosafety approval, but we began our work on SARS-CoV-2 to provide the first evidence for the immunity. I am very fortunate to have an extremely smart existence of a ternary complex existing and hardworking PhD student in Jaclyn Law, who in the between MHC II, peptide antigen, and past few months has had to completely pivot her PhD thesis Dr. Tania Watts the T cell receptor. In 1986, Dr. Watts work towards focusing on SARS-CoV-2 immunity. It was took up a faculty position at the University of Toronto Department also a very active collaboration with members of Mario of Immunology, where her research has been focused on T cell and Ostrowski’s team contributing their assays and expertise as viral immunity. -
Family in Amphioxus, the Basal Chordate TNF Receptor-Associated
Genomic and Functional Uniqueness of the TNF Receptor-Associated Factor Gene Family in Amphioxus, the Basal Chordate This information is current as Shaochun Yuan, Tong Liu, Shengfeng Huang, Tao Wu, Ling of September 26, 2021. Huang, Huiling Liu, Xin Tao, Manyi Yang, Kui Wu, Yanhong Yu, Meiling Dong and Anlong Xu J Immunol 2009; 183:4560-4568; Prepublished online 14 September 2009; doi: 10.4049/jimmunol.0901537 Downloaded from http://www.jimmunol.org/content/183/7/4560 Supplementary http://www.jimmunol.org/content/suppl/2009/09/14/jimmunol.090153 Material 7.DC1 http://www.jimmunol.org/ References This article cites 38 articles, 12 of which you can access for free at: http://www.jimmunol.org/content/183/7/4560.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 26, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Genomic and Functional Uniqueness of the TNF Receptor-Associated Factor Gene Family in Amphioxus, the Basal Chordate1 Shaochun Yuan, Tong Liu, Shengfeng Huang, Tao Wu, Ling Huang, Huiling Liu, Xin Tao, Manyi Yang, Kui Wu, Yanhong Yu, Meiling Dong, and Anlong Xu2 The TNF-associated factor (TRAF) family, the crucial adaptor group in innate immune signaling, increased to 24 in amphioxus, the oldest lineage of the Chordata. -
The Transcriptional Roles of ALK Fusion Proteins in Tumorigenesis
cancers Review The Transcriptional Roles of ALK Fusion Proteins in Tumorigenesis 1, 2, , 1, Stephen P. Ducray y , Karthikraj Natarajan y z, Gavin D. Garland z, 1, , 2,3, , Suzanne D. Turner * y and Gerda Egger * y 1 Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge CB20QQ, UK 2 Department of Pathology, Medical University Vienna, 1090 Vienna, Austria 3 Ludwig Boltzmann Institute Applied Diagnostics, 1090 Vienna, Austria * Correspondence: [email protected] (S.D.T.); [email protected] (G.E.) European Research Initiative for ALK-related malignancies; www.erialcl.net. y These authors contributed equally to this work. z Received: 7 June 2019; Accepted: 23 July 2019; Published: 30 July 2019 Abstract: Anaplastic lymphoma kinase (ALK) is a tyrosine kinase involved in neuronal and gut development. Initially discovered in T cell lymphoma, ALK is frequently affected in diverse cancers by oncogenic translocations. These translocations involve different fusion partners that facilitate multimerisation and autophosphorylation of ALK, resulting in a constitutively active tyrosine kinase with oncogenic potential. ALK fusion proteins are involved in diverse cellular signalling pathways, such as Ras/extracellular signal-regulated kinase (ERK), phosphatidylinositol 3-kinase (PI3K)/Akt and Janus protein tyrosine kinase (JAK)/STAT. Furthermore, ALK is implicated in epigenetic regulation, including DNA methylation and miRNA expression, and an interaction with nuclear proteins has been described. Through these mechanisms, ALK fusion proteins enable a transcriptional programme that drives the pathogenesis of a range of ALK-related malignancies. Keywords: ALK; ALCL; NPM-ALK; EML4-ALK; NSCLC; ALK-translocation proteins; epigenetics 1. Introduction Anaplastic lymphoma kinase (ALK) was first successfully cloned in 1994 when it was reported in the context of a fusion protein in cases of anaplastic large cell lymphoma (ALCL) [1]. -
TRAF2 Sirna Set I TRAF2 Sirna Set I
Catalog # Aliquot Size T57-911-05 3 x 5 nmol T57-911-20 3 x 20 nmol T57-911-50 3 x 50 nmol TRAF2 siRNA Set I siRNA duplexes targeted against three exon regions Catalog # T57-911 Lot # Z2097-85 Specificity Formulation TRAF2 siRNAs are designed to specifically knock-down The siRNAs are supplied as a lyophilized powder and human TRAF2 expression. shipped at room temperature. Product Description Reconstitution Protocol TRAF2 siRNA is a pool of three individual synthetic siRNA Briefly centrifuge the tubes (maximum RCF 4,000g) to duplexes designed to knock-down human TRAF2 mRNA collect lyophilized siRNA at the bottom of the tube. expression. Each siRNA is 19-25 bases in length. The gene Resuspend the siRNA in 50 µl of DEPC-treated water accession number is NM_021138. (supplied by researcher), which results in a 1x stock solution (10 µM). Gently pipet the solution 3-5 times to mix Gene Aliases and avoid the introduction of bubbles. Optional: aliquot TRAP, TRAP3, MGC: 45012 1x stock solutions for storage. Storage and Stability Related Products The lyophilized powder is stable for at least 4 weeks at room temperature. It is recommended that the Product Name Catalog Number lyophilized and resuspended siRNAs are stored at or TRAF2 Protein T57-30H below -20oC. After resuspension, siRNA stock solutions ≥2 Anti-TRAF2 T57-363BR µM can undergo up to 50 freeze-thaw cycles without Anti-TRAF2 T57-363R significant degradation. For long-term storage, it is Anti-TRAF3 T58-363R recommended that the siRNA is stored at -70oC. For most Anti-TRAF3 T58-363BR favorable performance, avoid repeated handling and multiple freeze/thaw cycles. -
And CD137L Responses by Dual Costimulation with CD80
Enhancement of HIV-Specific CD8 T Cell Responses by Dual Costimulation with CD80 and CD137L This information is current as Jacob Bukczynski, Tao Wen, Chao Wang, Natasha Christie, of September 28, 2021. Jean-Pierre Routy, Mohamed-Rachid Boulassel, Colin M. Kovacs, Kelly S. MacDonald, Mario Ostrowski, Rafick-Pierre Sekaly, Nicole F. Bernard and Tania H. Watts J Immunol 2005; 175:6378-6389; ; doi: 10.4049/jimmunol.175.10.6378 Downloaded from http://www.jimmunol.org/content/175/10/6378 References This article cites 57 articles, 30 of which you can access for free at: http://www.jimmunol.org/content/175/10/6378.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on September 28, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2005 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Enhancement of HIV-Specific CD8 T Cell Responses by Dual Costimulation with CD80 and CD137L1 Jacob Bukczynski,* Tao Wen,2* Chao Wang,* Natasha Christie,* Jean-Pierre Routy,† Mohamed-Rachid Boulassel,† Colin M. -
Erythropoietin Action in Stress Response, Tissue Maintenance and Metabolism
Int. J. Mol. Sci. 2014, 15, 10296-10333; doi:10.3390/ijms150610296 OPEN ACCESS International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Review Erythropoietin Action in Stress Response, Tissue Maintenance and Metabolism Yuanyuan Zhang 1, Li Wang 2, Soumyadeep Dey 1, Mawadda Alnaeeli 3,4, Sukanya Suresh 1, Heather Rogers 1, Ruifeng Teng 5 and Constance Tom Noguchi 1,* 1 Molecular Medicine Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA; E-Mails: [email protected] (Y.Z.); [email protected] (S.D.); [email protected] (S.S.); [email protected] (H.R.) 2 Faculty of Health Sciences, University of Macau, Macau SAR, China; E-Mail: [email protected] 3 Department of Biological Sciences, Ohio University, Zanesville, OH 43701, USA; E-Mail: [email protected] 4 Diabetes Institute, Ohio University, Athens, OH 45701, USA 5 Mouse Metabolism Core Laboratory, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +1-301-496-1163; Fax: +1-301-402-0101. Received: 20 February 2014; in revised form: 23 May 2014 / Accepted: 28 May 2014 / Published: 10 June 2014 Abstract: Erythropoietin (EPO) regulation of red blood cell production and its induction at reduced oxygen tension provides for the important erythropoietic response to ischemic stress. The cloning and production of recombinant human EPO has led to its clinical use in patients with anemia for two and half decades and has facilitated studies of EPO action.